How is the MoCA score interpreted?

26-30: Normal cognition. 18-25: Mild cognitive impairment (MCI). 10-17: Moderate cognitive impairment. Below 10: Severe cognitive impairment. Add 1 point if education is 12 years or fewer (maximum 30). Scores below 26 are a positive screen requiring further clinical evaluation — they do not confirm a dementia diagnosis.

How sensitive is MoCA for mild cognitive impairment?

In the original Nasreddine et al. (2005) validation study, the MoCA at threshold 26 had sensitivity 90% and specificity 87% for MCI compared to normal cognition, and sensitivity 100% for Alzheimer's dementia. Compared to the MMSE's sensitivity for MCI of only 18%, this represents a dramatic improvement in early detection capability. The MoCA's superior sensitivity for MCI is primarily due to its more challenging executive function, attention, and delayed recall tasks.

What are the MoCA administration instructions?

The MoCA requires: a printed administration sheet with the trail-making task, cube, and clock face; a pencil; and approximately 10 minutes of uninterrupted time. Administer all tasks in standardized order following the scoring sheet instructions. Document years of education. Apply the 1-point education correction for 12 or fewer years of schooling. The MoCA is available free for clinical use from mocatest.org for registered healthcare providers.

What is the difference between dementia and mild cognitive impairment?

MCI involves cognitive decline beyond normal aging but with preserved functional independence in daily activities (driving, managing finances, preparing meals). Dementia (major neurocognitive disorder) involves cognitive decline sufficient to impair independent daily function. The MoCA is sensitive for both: scores 18-25 are consistent with MCI, while scores below 18 with clinical history of functional impairment suggest dementia. Distinguishing MCI from dementia requires detailed functional assessment through clinical interview with the patient and an informant.

What screening tool should I use for Alzheimer's disease?

The MoCA is the recommended first-line cognitive screening tool for Alzheimer's disease and other dementias in most guidelines. Its 90% sensitivity for MCI and 100% sensitivity for Alzheimer's dementia in the original validation make it the most reliable brief screen available. The MMSE is an alternative when MoCA is not available but has much lower sensitivity for early disease. For screening in primary care where very brief instruments are preferred, the Mini-Cog (3-word recall plus clock drawing) provides good balance of brevity and sensitivity.

When should I apply the MoCA education adjustment?

The 1-point education correction should always be applied when the patient has 12 or fewer years of formal education, regardless of apparent educational attainment or linguistic ability. This correction is validated in the original MoCA publication and is specifically designed to reduce false-positive screening in populations with limited formal education. The correction is capped at 30 — a raw score of 29 or 30 cannot be adjusted higher. Document the raw score, the education correction, and the adjusted score in clinical records.

What are the treatment options for cognitive impairment detected by MoCA?

For Alzheimer's disease dementia: cholinesterase inhibitors (donepezil, rivastigmine, galantamine) are FDA-approved for mild-moderate disease; memantine for moderate-severe; anti-amyloid therapies (lecanemab, donanemab) for early Alzheimer's in specialized centers. For MCI: no FDA-approved medications, but aggressive vascular risk factor management, regular aerobic exercise, cognitive engagement, and treatment of depression may slow progression. All causes of reversible cognitive impairment (thyroid disease, B12 deficiency, NPH, medication toxicity) must be excluded and treated before attributing decline to neurodegeneration.

Online Medical Tools — MoCA Score

Printed on 8/14/2026

For informational purposes only. This is not medical advice.

Mental Health

MoCA Score

The Montreal Cognitive Assessment (MoCA) is a widely used cognitive screening tool designed to detect mild cognitive impairment (MCI) and early dementia. It assesses multiple cognitive domains: visuospatial/executive function, naming, memory, attention, language, abstraction, delayed recall, and orientation. Total score ranges from 0–30, with ≥26 considered normal. A 1-point education correction is added for individuals with ≤12 years of education. The MoCA has higher sensitivity than the MMSE for detecting MCI and is recommended by many neurology and geriatric guidelines as the preferred screening tool.

Formula: Total score 0–30. Add 1 point if education ≤12 years. Normal ≥26.

MoCA Raw Score

Years of Education

Save your results with a free account

Keep a history of calculations, favorite tools, and access your dashboard anytime.

Create free account Sign in

How It Works

Administer 7 Cognitive Domains in Approximately 10 Minutes

The MoCA assesses seven cognitive domains through standardized tasks. Visuospatial/executive function (5 points): trail making B-pattern connecting alternating numbers and letters, cube copy, and clock drawing with hands set to 11:10. Naming (3 points): identifying drawings of a lion, rhinoceros, and camel. Attention (6 points): forward and backward digit span, tapping on the letter A, and serial 7 subtractions. Language (3 points): repeating two complex sentences verbatim and generating words beginning with the letter F. Abstraction (2 points): explaining how two items are similar (train/bicycle; watch/ruler). Delayed recall (5 points): recalling 5 words learned earlier without cues. Orientation (6 points): correctly stating date, month, year, day of week, place, and city. Standardized administration materials are required.

Apply Education Correction and Calculate Total Score

After completing all seven domains, the raw scores are summed to produce a total between 0 and 30. One bonus point is added if the patient has 12 or fewer years of formal education, correcting for the known effect of lower education on cognitive test performance. This education-adjusted total is the score used for interpretation. The maximum possible adjusted score is 30 (the correction is capped at 30). Document whether the education adjustment was applied and the patient's years of education as part of the clinical record.

Interpret Score Against Validated Severity Bands

An adjusted score of 26 or above is considered normal. Scores of 18-25 suggest mild cognitive impairment (MCI), which requires further evaluation and clinical correlation. Scores of 10-17 indicate moderate cognitive impairment, and scores below 10 indicate severe impairment consistent with advanced dementia. A MoCA score below 26 is a positive screen — it does not diagnose dementia but indicates that further evaluation is warranted, including clinical history, neurological examination, laboratory workup, and neuroimaging.

Who Uses the MoCA Score

Primary Care Mild Cognitive Impairment Screening

General Practitioners

The MoCA is the recommended first-line cognitive screening tool when a patient or family member reports memory concerns. Its 90% sensitivity for MCI makes it far more reliable than the MMSE for detecting early cognitive decline before dementia develops.

Memory Clinic Initial Cognitive Assessment

Neurologists and Geriatricians

Memory clinics use the MoCA to quantify cognitive impairment severity at initial evaluation, guide the intensity of further neuropsychological workup, and stratify patients into MCI vs mild dementia categories for treatment eligibility and care planning.

Driving Capacity Assessment in Older Adults

Geriatricians and Occupational Therapists

MoCA scores below 18-20 are associated with significantly impaired driving simulator performance and increased real-world crash risk. The MoCA is used as part of formal driving fitness evaluations in many jurisdictions for older adults with cognitive concerns.

Pre-Surgical Cognitive Baseline Documentation

Anesthesiologists and Surgeons

Documenting a pre-operative MoCA baseline identifies patients at elevated risk for post-operative cognitive dysfunction (POCD) and delirium, enabling tailored anesthetic management and informed consent discussions about cognitive risks of surgery in older adults.

Alzheimer's Disease Longitudinal Monitoring

Neuropsychologists

Serial MoCA administration tracks the rate of cognitive decline in patients with established Alzheimer's disease or other dementias. A decline of 2 or more points per year suggests active progression; stability may reflect treatment response or slow-progression disease.

Dementia Medication Eligibility Assessment

Geriatric Psychiatrists

Cholinesterase inhibitors and memantine have approved indications for specific dementia severity ranges. MoCA scores document cognitive severity and support insurance authorization and clinical guidelines for initiating or adjusting anti-dementia medications.

Pro Tips

MoCA Detects MCI With 90% Sensitivity vs 18% for MMSE

The Montreal Cognitive Assessment is dramatically more sensitive than the MMSE for detecting mild cognitive impairment. At the validated cutoff of 26, MoCA sensitivity for MCI is 90% compared to only 18% for the MMSE. This difference occurs because the MoCA includes more challenging executive function, attention, and memory tasks that reveal early-stage decline missed by the MMSE's simpler items. Always use the MoCA rather than MMSE when the clinical question involves possible MCI.

MoCA Requires In-Person Administration — Cannot Be Done by Telephone

The MoCA includes drawing tasks (trail making, cube copy, clock drawing) and verbal fluency tasks that require the examiner to observe the patient. Standard MoCA cannot be administered by telephone. A validated telephone version (T-MoCA) exists that omits visual tasks and adjusts cutoffs, but it is not interchangeable with the standard MoCA. Always use the standard face-to-face version for clinical assessments and document the administration method.

Always Apply the Education Correction Point

Add 1 point to the raw MoCA score for patients with 12 or fewer years of formal education. This correction accounts for the systematically lower performance on cognitive tests in less-educated populations without neurodegenerative disease. The correction is capped at 30 — it should not push a score above 30. Failure to apply this correction will falsely classify many cognitively normal individuals with limited education as impaired.

MCI Is Not Dementia — It Is a Risk State

A MoCA score of 18-25 with clinical correlation suggests mild cognitive impairment (MCI), not dementia. MCI represents cognitive decline greater than expected for age but with preserved functional independence in daily activities. Approximately 10-15% of MCI patients convert to dementia per year, making follow-up and risk factor management critical. Educate patients that MCI is not inevitable progression — some patients remain stable or even improve.

MoCA Screens — It Does Not Diagnose Dementia

A MoCA score below 26 is a positive screen, not a diagnosis. Dementia diagnosis requires: documented cognitive decline from prior level, impairment in two or more cognitive domains, functional impairment in daily activities, and ruling out delirium. The evaluation also requires clinical history, collateral informant interview, neurological examination, laboratory workup (thyroid, B12, metabolic panel), and often neuroimaging. Never diagnose dementia based on MoCA alone.

Know the Four Major Dementia Subtypes on MoCA

Different dementia subtypes produce different MoCA profiles. Alzheimer's disease: prominent memory (delayed recall) impairment, gradual onset. Vascular dementia: executive function and attention impairment predominate, stepwise progression with focal neurological signs. Lewy body dementia: fluctuating cognition plus visual hallucinations plus parkinsonism — visuospatial tasks often severely impaired. Frontotemporal dementia: executive function and language affected; memory may be relatively spared initially.

Cognitive Reserve Affects Score Interpretation

Patients with higher education and more cognitively complex careers have greater cognitive reserve, meaning they may have substantial neurodegenerative pathology before MoCA scores fall below 26. A highly educated professor scoring 23 may have more underlying pathology than a less-educated individual scoring 20. Serial MoCA testing and comparison to the patient's personal estimated baseline is more informative than single-point cutoffs in high-reserve individuals.

MoCA-Basic Is Available for Low-Literacy Populations

The MoCA-Basic is a validated alternate version designed for populations with limited literacy or very low education. It uses simpler verbal instructions and omits tasks heavily dependent on reading and writing. For populations in developing countries or with very low educational attainment, the MoCA-Basic may be more appropriate than the standard version. Document which version was used in clinical records.

Cholinesterase Inhibitors Provide Modest Functional Benefit in Alzheimer's

Donepezil, rivastigmine, and galantamine are FDA-approved cholinesterase inhibitors for mild-moderate Alzheimer's disease dementia. They provide modest but clinically meaningful improvement in cognitive and functional outcomes, with effect sizes equivalent to approximately 6-12 months of disease progression delay. Memantine is approved for moderate-severe Alzheimer's. Anti-amyloid therapies (lecanemab, donanemab) represent newer disease-modifying approaches for early Alzheimer's disease.

Practice Effects Can Inflate Repeat MoCA Scores

Patients who have been administered the MoCA before may score higher on repeat testing due to learning and memory of specific test items, particularly the 5-word recall task. Practice effects can inflate scores by 2-4 points, potentially masking true cognitive decline or falsely suggesting improvement. When repeated testing is required at short intervals (less than 6 months), consider using an alternate form of the MoCA or supplementing with other cognitive measures to distinguish true change from practice effect.

Common Questions About Your Results

For detecting mild cognitive impairment, the MoCA is substantially better than the MMSE, with sensitivity of 90% vs 18% at their respective cutoffs. The MMSE's ceiling effect causes it to miss most patients with MCI. The MoCA is the current recommended first-line cognitive screening tool in most neurology, geriatrics, and memory clinic guidelines. The MMSE retains value for tracking progression in patients already diagnosed with moderate to severe dementia where its scoring range provides adequate resolution. If the clinical question is 'Does this patient have MCI?', use the MoCA.

Patients with severe arthritis, tremor, stroke-related hemiparesis, or other motor impairment cannot validly complete the MoCA's visuospatial tasks (trail making, cube copy, clock drawing), which account for 5 of 30 points. In such cases, the standard MoCA is not administrable and scores will be artificially depressed. Options include: administering only the non-motor subtests and scoring out of the remaining available points, using a verbal-only cognitive test (such as the Telephone Interview for Cognitive Status), documenting the motor limitation and the incomplete administration, or referring for formal neuropsychological evaluation that can adapt testing for motor impairment.

A score of 24 (below the normal cutoff of 26) that conflicts with collateral family report requires further investigation rather than immediate reassurance or diagnosis. First, ensure the education correction was applied if appropriate. Second, assess for treatable causes of cognitive test impairment: depression, anxiety, sleep deprivation, medication side effects, hypothyroidism, B12 deficiency. Administer the PHQ-9 to screen for depression. Third, administer the MMSE for comparison. If the MoCA score persists below 26 on a repeat assessment after excluding confounders, further workup including laboratory evaluation and neuroimaging is appropriate.

Standard MoCA cannot be administered by telephone because drawing tasks are essential components. A validated Telephone MoCA (T-MoCA) exists that omits visuospatial drawing items, uses adjusted cutoffs, and has been validated as a remote cognitive screening tool. Video-based administration of the standard MoCA is possible if the patient can hold drawings up to the camera, but standardization is reduced. If remote administration is necessary, use the validated T-MoCA and document the administration method, as T-MoCA scores are not directly comparable to standard MoCA scores.

A positive MoCA screen (score below 26) should prompt evaluation to identify reversible causes of cognitive impairment before attributing decline to neurodegeneration. Standard workup includes: complete blood count, comprehensive metabolic panel, thyroid-stimulating hormone, vitamin B12, folate, fasting glucose, lipid panel, and urinalysis. Consider RPR/VDRL for syphilis and HIV testing based on risk factors. Neuroimaging (MRI brain preferred over CT for structural detail) identifies strokes, white matter disease, atrophy patterns, normal pressure hydrocephalus, and subdural hematoma. Abnormal findings on initial workup guide further specialized evaluation.

Evidence-Based Methodology

MoCA published by Nasreddine et al. (J Am Geriatr Soc 2005) from 277 patients. Sensitivity 90% and specificity 87% for MCI vs normal at threshold 26. Sensitivity 100% for Alzheimer's dementia. Compared to MMSE sensitivity for MCI of 18%. MoCA copyright: available free for clinical use from mocatest.org for healthcare providers. International validation in 100+ countries. MCI annual conversion to dementia: Petersen et al. (Arch Neurol 2001). NIA-AA Alzheimer's criteria: McKhann et al. (Alzheimers Dement 2011).

Clinical Content Trust

Last reviewed:: April 21, 2026
Guideline version:: General evidence framework v2026.04
Source set version:: Primary-source set v1

How to Interpret Your Result

Your adjusted MoCA score (with education correction if applicable) indicates cognitive function across multiple domains. A score of 26 or above is considered normal. Scores of 18-25 suggest mild cognitive impairment (MCI), which may represent early neurodegenerative disease, vascular cognitive impairment, or other treatable causes of cognitive decline. Scores of 10-17 suggest moderate cognitive impairment consistent with dementia. Scores below 10 suggest severe cognitive impairment.

A low MoCA score is not a diagnosis — it is a screening result that warrants further evaluation. Many conditions can cause cognitive impairment, including depression, medication side effects, sleep apnea, thyroid dysfunction, vitamin B12 deficiency, and normal pressure hydrocephalus, some of which are reversible. A comprehensive evaluation including neuropsychological testing, laboratory workup, and neuroimaging may be appropriate.

When to Use This Tool

Use the MoCA score interpreter when a Montreal Cognitive Assessment has been administered and you need to contextualize the result. The MoCA is recommended as a first-line cognitive screening tool for patients with subjective memory complaints, for older adults during routine health evaluations, and for patients with conditions associated with cognitive decline (stroke, Parkinson disease, heart failure, diabetes).

It is also used for serial monitoring of cognitive function over time — for example, tracking progression in patients with known MCI or assessing response to cholinesterase inhibitor therapy. A decline of 2 or more points on serial testing may be clinically meaningful, though practice effects can artificially inflate repeat scores.

Limitations

The MoCA is a screening tool, not a diagnostic instrument. A score below 26 does not confirm dementia or MCI, and a score of 26 or above does not exclude it. The standard cutoff of 26 has high sensitivity but lower specificity, meaning some cognitively normal individuals will screen positive. Some experts have suggested that a cutoff of 23 may be more appropriate in certain populations to reduce false positives.

The MoCA is influenced by education, language, and cultural factors. The 1-point education correction for individuals with 12 or fewer years of education is a rough adjustment and may not fully account for educational disparities. Performance can also be affected by anxiety, fatigue, sensory impairments (hearing or vision), and the testing environment. The MoCA should not be used as a standalone tool for major clinical decisions such as driving fitness or capacity assessments without comprehensive neuropsychological evaluation.

Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.

Changelog

April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.

Related Tools

Mental Health

MMSE Score

Interpret Mini-Mental State Examination (MMSE) scores. The classic cognitive screening test for dementia, scoring 0–30.

Open Geriatrics

CAM Delirium Screen

Screen for delirium using the CAM (Confusion Assessment Method). Gold standard with ~94% sensitivity and ~89% specificity. Requires acute onset + inattention, plus disorganized thinking or altered consciousness.

Open Geriatrics

Clinical Frailty Scale

Assess frailty using the Rockwood Clinical Frailty Scale (CFS 1–9): Very Fit to Terminally Ill. Used for hospice eligibility, prognostication, ICU triage, surgical risk stratification, and goals-of-care discussions.

Open Emergency

Glasgow Coma Scale

Calculate the Glasgow Coma Scale score to assess level of consciousness. Used worldwide in emergency medicine and trauma assessment.

Open

Frequently Asked Questions

The MoCA (Montreal Cognitive Assessment) is a 30-point cognitive screening test developed by Dr. Ziad Nasreddine. It takes approximately 10 minutes to administer and tests seven cognitive domains: visuospatial/executive function, naming, attention, language, abstraction, delayed recall, and orientation. One point is added for education of 12 years or less. It is the most sensitive brief cognitive screening test for mild cognitive impairment.

A MoCA score of 26 or above is considered normal. A score of exactly 26 is at the threshold — if the patient has 12 or fewer years of education and received the education correction, their raw score was 25, which without the correction would indicate mild cognitive impairment. Borderline scores (24-26) should be interpreted in clinical context including the patient's education, baseline function, and any confounding factors such as depression or medication effects.

The MoCA is significantly more sensitive than the MMSE for detecting mild cognitive impairment (90% vs 18% sensitivity). The MoCA includes harder executive function tasks, a more demanding 5-word memory test, and visuospatial/abstraction tasks that reveal early cognitive decline missed by the MMSE. The MMSE has a normal cutoff of 24 vs 26 for MoCA. Most current guidelines recommend the MoCA as the preferred first-line cognitive screening tool.

MCI is cognitive decline greater than expected for age and education but with preserved functional independence in daily activities. A MoCA score of 18-25 with clinical correlation is consistent with MCI. Approximately 10-15% of MCI patients progress to dementia annually. MCI is not inevitable dementia — some patients remain stable. Risk factor modification (treating vascular risk factors, physical exercise, cognitive engagement) may reduce conversion risk.

No. The MoCA is a screening tool, not a diagnostic instrument for any specific dementia. Diagnosing Alzheimer's disease requires clinical history documenting gradual memory decline, collateral informant interview, neurological examination, laboratory workup to exclude reversible causes, neuroimaging, and clinical criteria (NIA-AA 2011). Biomarker confirmation (amyloid PET, tau PET, or CSF biomarkers) is increasingly used in specialized settings. A low MoCA score initiates this workup but does not itself diagnose Alzheimer's.

Online Medical Tools — MoCA Score

MoCA Score

How It Works

Administer 7 Cognitive Domains in Approximately 10 Minutes

Apply Education Correction and Calculate Total Score

Interpret Score Against Validated Severity Bands

Who Uses the MoCA Score

Primary Care Mild Cognitive Impairment Screening

Memory Clinic Initial Cognitive Assessment

Driving Capacity Assessment in Older Adults

Pre-Surgical Cognitive Baseline Documentation

Alzheimer's Disease Longitudinal Monitoring

Dementia Medication Eligibility Assessment

Pro Tips

MoCA Detects MCI With 90% Sensitivity vs 18% for MMSE

MoCA Requires In-Person Administration — Cannot Be Done by Telephone

Always Apply the Education Correction Point

MCI Is Not Dementia — It Is a Risk State

MoCA Screens — It Does Not Diagnose Dementia

Know the Four Major Dementia Subtypes on MoCA

Cognitive Reserve Affects Score Interpretation

MoCA-Basic Is Available for Low-Literacy Populations

Cholinesterase Inhibitors Provide Modest Functional Benefit in Alzheimer's

Practice Effects Can Inflate Repeat MoCA Scores

Common Questions About Your Results

Evidence-Based Methodology

Clinical Content Trust

How to Interpret Your Result

When to Use This Tool

Limitations

Changelog

Related Tools

MMSE Score

CAM Delirium Screen

Clinical Frailty Scale

Glasgow Coma Scale

Further Reading

Mental Health Screening Guide: Depression, Anxiety, Substance Use, and Cognitive Assessment

Frequently Asked Questions